Guenther Kaiser

Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach

Christian Bartels, Michael Looby, Romain Séchaud et al. · British Journal of Clinical Pharmacology · 2013 · 51 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Omalizumab Protects against Allergen- Induced Bronchoconstriction in Allergic (Immunoglobulin E-Mediated) Asthma

Stefan Zielen, A. Lieb, Stephan De La Motte et al. · International Archives of Allergy and Immunology · 2012 · 44 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing table

Oliver Kornmann, Henrik Watz, Rainard Fuhr et al. · Pulmonary Pharmacology & Therapeutics · 2014 · 37 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Pharmacokinetics of multiple inhaled NVA237 doses in patients with chronic obstructive pulmonary disease (COPD)

Romain Séchaud, Didier Renard, Lixin Zhang- uberson et al. · International Journal of Clinical Pharmacology and Therapeutics · 2011 · 32 citations

Medicine, Pharmacokinetics, Pharmacology +17

Population pharmacokinetics and optimal design of paediatric studies for famciclovir

Kayode Ogungbenro, Ivan Matthews, Michael Looby et al. · British Journal of Clinical Pharmacology · 2009 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16